Navigation Links
Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen
Date:4/18/2008

Berlin, Germany: Acupuncture provides effective relief from hot flushes in women who are being treated with the anti-oestrogen tamoxifen following surgery for breast cancer, according to new research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.

Mrs Jill Hervik, a physiotherapist and acupuncturist at the Vestfold Central Hospital (Tnsberg, Norway), told a news briefing that breast cancer patients who received traditional Chinese acupuncture had a 50% reduction in hot flushes, both during the day and the night, and that this effect continued after the acupuncture ceased.

Acupuncture is increasingly used in western countries to treat the problem of hot flushes in healthy post-menopausal women, so we wanted to see whether it was effective in women with breast cancer suffering from hot flushes as a result of their anti-oestrogen medication, she said.

Tamoxifen can cause many of the symptoms that occur during the menopause, including hot flushes. For healthy women, hormone replacement therapy has traditionally been used to alleviate symptoms, but it is associated with an increased risk of relapse in women with oestrogen sensitive breast cancers.

In a prospective, single-blind, controlled trial, Mrs Hervik and her supervisor, Dr Odd Mjland, randomised 59 breast cancer patients to receive either ten weeks of traditional Chinese acupuncture or sham (minimal) acupuncture between March 2003 and December 2006. All were taking tamoxifen following surgery and were postmenopausal. She delivered both the real and the sham acupuncture to the patients, and maintained a neutral treatment atmosphere (e.g. no soft music, and minimal time spent talking to the patients) in order to reduce the placebo effect of the treatments.

The patients recorded the number of hot flushes they experienced for four weeks before the treatment, during the treatment and during a 12-week follow-up period. Other meno
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Even Sham Acupuncture Eases Low Back Pain
2. Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does
3. Acupuncture School Gives Free Acupuncture Treatments
4. Acupuncture Cuts Need for Post-Op Painkillers
5. Acupuncture May Aid In Vitro Fertilization
6. Warning! Doctors, Insurers Hold Patients Hostage! Says Top Acupuncture Physician
7. Community Acupuncture Events Commemorate World Health Day 2008 Acupuncture Fundraiser at AOMA on Monday April 7th, 9am-4pm
8. SNAP! CRACKLE! POP! Untrained Chiropractors Doing Acupuncture!
9. New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
10. Strength training of neck muscles relieves chronic pain
11. Survival differences by race most apparent in advanced stages of breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ctoryPharma,Inc.("Victory")announcedtodaythelaunch...y,sNAPRELANfranchise. ,, NAPRELANDoseCardisdesi...ainandinflammationassociatedwithprimarydysmenorrhe...patientssufferingfromrheumatoidarthritisorosteoart...onalanti-inflammatory/analgesicactivityforalimited...
(Date:11/23/2009)...n the November issue of GIE: Gastrointestinal End...nal of the American Society for Gastrointestinal E...y found that Barrett,s esophagus was detected in s...opic screening. Also in this issue, two studies ex...om France, in the largest single-center experience...
(Date:11/23/2009)...build-up of a brain peptide called amyloid-beta. T...us of almost all drug research pursuing a cure for...But that may be counterproductive, says Dr. Inna S...iology and Pharmacology, Sackler Faculty of Medici...beta is also necessary to maintain proper brain fu...
(Date:11/23/2009)...Call/--AnnTaylorStoresCorp.announcedtodaythatitwil...sandGivingcampaign,aholidayfundraisingandawareness...armarksthethirdyearthatAnnTaylor,throughitsANNCARE...mpaignwhereweofferourshoppersanopportunitytohelpsa...hisholidayseason.ClientswhoshopatAnnTaylor,Loft,An...
(Date:11/23/2009)...ed longer-term support than most friends, relative...ing to a study of 160 patients published in the De...Nursing . , Researchers surveyed 55 patients...her with 105 who had had surgery in the last one t...in Tennessee, USA. They wanted to see if there was...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3
...ntists from University of California have develope...cells which could help in the treatment of spinal ...ing results in the stimulation of nerve cells in l...oung and doesnot grow when it has become old, the ...
...essor Karen Gripp and his team from DuPont Hospita...ad to Costello Syndrome, scientists found that the...it was not observed in the genotype of the parents...don 12 or 13 in the H-ras gene in 85% patients. Th...
...Lancet has published a new study which challenges ...od to the heart. The study asserts that the harm i...benefits. Conventional medical wisdom states that ...ealand cite a large US study published earlier thi...
...search team of scientists at the Columbia Universi...eight when compared to keeping it off. // The key ...ppetite. The hormone helped people to avoid puttin...he metabolic thermostat of the body is reset upwar...
...galese schoolchildren took a pledge to abstain fro...DS Day. The prevailing taboos in the developing na...ntributing towards the disease spreading rapidly. ...courge is continuing to take a heavy toll in the A...
...ish researchers have expressed hope regarding the ...virus. The first phase of the clinical trials have...volunteers. DNA vaccines represent the lates... vaccines precipitate an immune response so that t...
Other Medicine News:Health News:DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope 2
(Date:11/23/2009)...ire-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"...sentationofclinicaltrialdataonNGX426,theCompany,so...ntagonist,atthe12thInternationalConferenceontheMec...r20-21inSanFrancisco.TheresultsofthestudyledbyMark...eCenterforPainMedicineoftheUniversityofCaliforniaa...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 1HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 2HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 3Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2
...Mo.--(BUSINESS WIRE)--May 4, 2007 - New data have,...erosis (RRMS),patients treated with COPAXONE(R) (g...osuppression with mitoxantrone experienced a,90 pe...)-monitored,disease activity compared to their bas...ere sustained throughout the 24-month study,period...
...ngland, 4th May 2007 - CeNeS Pharmaceuticals plc,(...ompany, notes,the publication of an independent st... on its Phase II NMDA antagonist, CNS 5161. CeNeS,...r neuropathic,pain. The independent study builds o...CNS 5161. , In the study reported in ,Synapse, Dr...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Vitreoretinal Viscodissector 90 degrees
Infusion Cannula 6mm
DCR Set
IOL Manipulator - Sinskey
Medicine Products: